Steatocystoma multiplex (STM) is a rare skin disorder characterized by the formation of multiple follicular cysts filled with sebum. These cysts are usually located on the trunk, shoulders, and chest, but can also appear on other areas of the skin. Clinically, the disease manifests itself as painless, mobile, soft, yellowish or skin-colored lesions that can vary in size from a few millimeters to several centimeters in diameter. Steatocystoma multiplex is associated with abnormalities in the structure of the sebaceous glands, which may explain its predominant occurrence in patients with increased sebum secretion.
History of the disease and interesting historical facts
Steatocystoma multiplex was first described in the medical literature in the mid-20th century. A study conducted in 1970 was the first to clearly define the disease and identify it as a separate nosological entity. Interestingly, until that time, multiple sebaceous cysts were grouped with other dermatological conditions such as cheilitis or acne. Since then, research has focused on the pathogenesis, clinical manifestations, and treatment methods of this pathology.
Epidemiology
According to current data, the incidence of steatocystoma multiplex ranges from 1 to 2 cases per 1000 people. The disease usually occurs in young people and adults aged 20 to 40 years, with no pronounced gender predisposition. However, this disease can occur in both men and women, and its prevalence may vary depending on ethnicity and environmental conditions.
Genetic predisposition to this disease
Research suggests that steatocystoma multiplex may have a genetic predisposition. Affected patients often have a family history of diseases associated with the formation of skin cysts. Mutations in the KRT17 and KRT17 genes have now been identified that may be associated with the development of this condition. Understanding the molecular mechanisms that lead to the formation of steatocystomas opens up prospects for new diagnostic and therapeutic methods.
Risk factors for the development of this disease
There are several factors that potentially increase the risk of developing steatocystoma multiplex, including:
- Genetic predisposition
- Increased sebum secretion
- Disorders of the sebaceous glands
- The influence of environmental factors such as solar radiation and pollution
- Problems with the immune system
Diagnosis of this disease
Diagnosis of steatocystoma multiplex is based on clinical examination and symptoms, which include:
- The appearance of multiple soft formations on the skin
- Increase in brush size over time
- Absence of inflammation and pain
Laboratory studies may include analysis of fluid from the cysts to rule out infection. Radiologic studies are not necessary for diagnosis but may be used in complicated cases. The differential diagnosis includes conditions such as dermoid cysts, keratoacanthomas, and other forms of sebaceous masses.
Treatment
Treatment of steatocystoma multiplex is aimed at eliminating cosmetic defects and preventing the formation of new cysts. The main approaches include:
- Surgical excision of cysts
- Laser therapy
- Pharmacological treatment, including corticosteroids to reduce inflammation
It is important to note that spontaneous resolution of cysts is rare and, if necessary, the intervention can be performed under local anesthesia.
List of medications used to treat this disease
Medications used to treat steatocystoma multiplex include:
- Corticosteroids (to reduce inflammation and swelling)
- Antibiotics (for cyst infection)
- Non-systemic anti-inflammatory drugs (for pain management)
Disease monitoring
Monitoring of patients with steatocystoma multiplex should include regular examinations by a dermatologist to monitor cyst growth and identify new lesions. The prognosis is generally good, but complications such as infection or relapse may occur in rare cases. Possible complications include:
- Skin infection
- Recurrence of cysts after surgical removal
- Keloid scars
Age-related features of the disease
Steatocystoma multiplex is less common in children and adolescents than in adults. Elderly patients may have a more severe course of the disease with the development of additional lesions. In young people, the disease is more often associated with sebum secretion disorders, while in older patients, decreased activity of the sebaceous glands may be observed.
Questions and Answers
- What are the main symptoms of steatocystoma multiplex? The main symptoms include multiple soft growths on the skin that are painless and usually yellowish in color.
- How is this disease diagnosed? Diagnosis is based on clinical examination, possibly with additional analysis of fluid from the cysts.
- Can steatocystoma multiplex be prevented? There is no specific prevention, but avoiding risk factors can help reduce the likelihood of developing the disease.
- What treatment is available for a patient with steatocystoma? Treatment includes surgical removal of cysts, laser therapy, and, in some cases, drug therapy.
- What is the prognosis for patients with steatocystoma multiplex? The prognosis is generally good, but regular monitoring is necessary to prevent possible relapses.
